On 10/10/25, Ceva Inc (NASDAQ: CEVA) stock suffered a major decline of -12.2%, closing at $26.91. Moreover, this decline was accompanied by unusually high trading volume at 152% of normal. Relative to the market the […]
Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $7.96 on 10/10/25 after a major increase of 11.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 345% of normal. The stock has risen […]
Xunlei Ltd (NASDAQ: XNET) stock suffered a major decline of -15.4% on 10/10/25. The shares closed at $8.48. Moreover, above average trading volume at 129% of normal accompanied the decline. Relative to the market the […]
TSS Inc (NASDAQ: TSSI) stock closed at $17.67 on 10/10/25 after a major decline of -11.1%. Moreover, this decline was accompanied by above average trading volume at 122% of normal. The stock has declined -6.8% […]
On 10/10/25, Olin Corp (NYSE: OLN) stock suffered a major decline of -10.3%, closing at $22.28. Trading volume in this decline was normal. Relative to the market the stock has been weak over the last […]
Neogen Corp (NASDAQ: NEOG) stock suffered a major decline of -10.9% on 10/10/25. The shares closed at $6.04. Moreover, trading volume in this decline was above average at 141% of normal. The stock has been […]
Inseego Corp (NASDAQ: INSG) stock suffered a major decline of -12.4% on 10/10/25. The shares closed at $14.37. Trading volume in this decline was normal. The stock has performed in line with the market over […]
On 10/10/25, Entegris Inc (NASDAQ: ENTG) stock suffered a major decline of -11.2%, closing at $83.64. Moreover, unusually high trading volume at 160% of normal accompanied the decline. Relative to the market the stock has […]
U.S. Antimony Corp (NYSEAMERICAN: UAMY) stock enjoyed a major increase of 14.3% on 10/9/25. The shares closed at $10.88. Moreover, trading volume in this advance was exceptionally high at 226% of normal. The stock has […]
Cidara Therapeutics Inc (NASDAQ: CDTX) stock closed at $110.76 on 10/9/25 after a major increase of 12.4%. Moreover, this advance was accompanied by exceptionally high trading volume at 207% of normal. The stock has been […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research